Abbott challenges $1.67 billion patent loss to Johnson & Johnson
Abbott Laboratories urged a U.S. appeals court to throw out a $1.67 billion patent-infringement verdict, the largest in U.S. history, set after a jury found the company used Johnson & Johnson's technology to develop the arthritis drug Humira. Abbott is focusing its appeal on the validity of the patent, co-issued to New York University and Johnson & Johnson's Centocor unit. Humira, Abbott's biggest drug, includes human antibodies that aren't covered by the patent, a lawyer for the Abbott Park, Illinois-based company said.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063